raloxifene-diphosphate

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Nameraloxifene-diphosphate
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLysine-specific histone demethylase 1 inhibitorsEstrogen receptors modulators
TargetsEstrogen receptorsLysine-specific histone demethylase 1
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesState University of New York at Stony Brook
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesState University of New York at Stony Brook
Active IndicationsN/A
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A